Antibodies, Bacterial

• 

  Subject Areas on Research

  • A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk. 
  • A brief review. Poststreptococcal glomerulonephritis. 
  • A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques. 
  • A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen. 
  • A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities. 
  • A link between chronic asthma and chronic infection. 
  • A novel neurotoxoid vaccine prevents mucosal botulism. 
  • A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. 
  • A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. 
  • A quantitative fluorescent method for measurement of bacterial adherence and phagocytosis. 
  • A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali. 
  • An epidemic of Oroya fever in the Peruvian Andes. 
  • Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli. 
  • Antibiotics and coronary heart disease. 
  • Antibody response of 18 month old children 1 month and 18 months following Haemophilus influenzae type b vaccine administered singly or with DTP vaccine. 
  • Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. 
  • Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis. 
  • Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. 
  • B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. 
  • Brazilian spotted fever in Espirito Santo, Brazil: description of a focus of infection in a new endemic region. 
  • Campylobacter enteritis: clinical and epidemiologic features. 
  • Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia. 
  • Characterization of antibodies to bacterial double-stranded DNA in the sera of normal human subjects. 
  • Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. 
  • Chlamydia pneumoniae and acute coronary syndrome. 
  • Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules. 
  • Clinical characteristics in 53 patients with cat scratch optic neuropathy. 
  • Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi. 
  • Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. 
  • Comparison of acellular pertussis-diphtheria-tetanus toxoids and Haemophilus influenzae type b vaccines administered separately vs. combined in younger vs. older toddlers. 
  • Comparison of the Estimated Incidence of Acute Leptospirosis in the Kilimanjaro Region of Tanzania between 2007-08 and 2012-14. 
  • Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age. 
  • Complement resistance in microbes. 
  • Conditions for conducting the indirect hemolysis test for detection of antibodies to Brucella abortus. 
  • Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. 
  • Deficient expression of antibodies specific for bacterial DNA by patients with systemic lupus erythematosus. 
  • Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA. 
  • Detection of Bartonella species in the blood of veterinarians and veterinary technicians: a newly recognized occupational hazard? 
  • Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines. 
  • Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharide. 
  • Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity. 
  • Development of a serological test for Haemophilus ducreyi for seroprevalence studies. 
  • Diagnostic evaluation of a nanobody with picomolar affinity toward the protease RgpB from Porphyromonas gingivalis. 
  • Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen. 
  • Direct fluorescent antibody testing for endocervical Chlamydia trachomatis: factors affecting accuracy. 
  • Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes. 
  • Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination. 
  • Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1. 
  • Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon. 
  • Evaluation of pertussis in U.S. Marine Corps trainees. 
  • Evidence for unapparent Brucella canis infections among adults with occupational exposure to dogs. 
  • Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infection. 
  • Examination of type IV pilus expression and pilus-associated phenotypes in Kingella kingae clinical isolates. 
  • Exposure to Streptococcus suis among US swine workers. 
  • Failure of benzathine penicillin in a case of seronegative secondary syphilis in a patient with acquired immunodeficiency syndrome: case report and review of the literature. 
  • First Identification and Description of Rickettsioses and Q Fever as Causes of Acute Febrile Illness in Nicaragua. 
  • Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: A pooled analysis of prospective studies in China, Japan, and Korea. 
  • Genetic control of the immune response to staphylococcal nuclease. VII. Role of non-H2-linked genes in the control of the anti-nuclease antibody response. 
  • Genetic control of the immune response to staphylococcal nuclease. VIII. Mapping of genes for antibodies to different antigenic regions of nuclease. 
  • Genomic correlates of variability in immune response to an oral cholera vaccine. 
  • Haemophilus influenzae type b infection after nephrotic syndrome in a previously vaccinated child. 
  • Hallucinations, sensory neuropathy, and peripheral visual deficits in a young woman infected with Bartonella koehlerae. 
  • Helicobacter pylori Biomarkers and Risk of Colorectal Oncogenesis--Response. 
  • Helicobacter pylori blood biomarker for gastric cancer risk in East Asia. 
  • Helicobacter pylori detection and genotyping in gastric biopsy specimens from Chennai patients (India). 
  • Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. 
  • Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. 
  • Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants. 
  • Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study. 
  • High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A. 
  • Human Rickettsia felis infection, Canary Islands, Spain. 
  • Human anti-pneumococcal polysaccharide antibodies are secreted by the CD5- B cell lineage. 
  • IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection. 
  • Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. 
  • IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111. 
  • Immune responses to DNA in normal and aberrant immunity. 
  • Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. 
  • Immunization against Haemophilus influenzae. 
  • Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. 
  • Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge. 
  • Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface. 
  • Immunoblot analysis of anti-Ureaplasma urealyticum antibody in pregnant women and newborn infants. 
  • Immunochemical properties of anti-DNA antibodies in the sera of patients with Escherichia coli bacteremia. 
  • Immunodeficiencies. 
  • Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study. 
  • Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease. 
  • Immunogenicity of Haemophilus influenzae type b protein conjugate vaccines in very low birth weight infants. 
  • Immunoradiometric assay for examination and quantitation of Brucella abortus-specific antibodies reactive with the antigen(s) used in the indirect hemolysis test. 
  • Impaired antibody response to polysaccharides in association with functional asplenia. 
  • Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. 
  • In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity. 
  • In vivo protein expression and immune responses generated by DNA vaccines expressing mycobacterial antigens fused with a reporter protein. 
  • Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. 
  • Inherited deficiency of C8 in a patient with recurrent meningococcal infections: further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system. 
  • Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. 
  • Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA. 
  • Issues in cerebrospinal fluid management. CSF Venereal Disease Research Laboratory testing. 
  • Leptospirosis and human immunodeficiency virus co-infection among febrile inpatients in northern Tanzania. 
  • Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. 
  • Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. 
  • Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. 
  • Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. 
  • Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure. 
  • Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. 
  • Monitoring Anti-Pythium insidiosum IgG Antibodies and (1→3)-β-d-Glucan in Vascular Pythiosis. 
  • Neighborhood socio-economic characteristics, African ancestry, and Helicobacter pylori sero-prevalence. 
  • Neisseria meningitidis bacteremia in association with deficiency of the sixth component of complement. 
  • Neonatal pertussis, cocooning and maternal immunization. 
  • Neuroborreliosis with progression from pseudotumor cerebri to aseptic meningitis. 
  • No serologic evidence of an association found between Gulf War service and Mycoplasma fermentans infection. 
  • Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant. 
  • One-time screening to define the problem: Legionella exposure in an electric power company. 
  • Opsonic requirements for intravascular clearance after splenectomy. 
  • Oral vaccine models: multiple delivery systems employing tetanus toxoid. 
  • Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy. 
  • Penicillin resistance is not extrapolable to amoxicillin resistance in Streptococcus pneumoniae isolated from middle ear fluid in children with acute otitis media. 
  • Persistence of Campylobacter fetus bacteremia associated with absence of opsonizing antibodies. 
  • Prevalence of antibodies to spotted fever group rickettsiae in dogs from southeastern Australia. 
  • Prevention of pneumococcal infection in a patient with normal immunoglobulin levels but impaired polysaccharide antibody production. 
  • Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. 
  • Pseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide. 
  • Q Fever, Scrub Typhus, and Rickettsial Diseases in Children, Kenya, 2011-2012. 
  • Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women. 
  • Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. 
  • Recurrent expressive aphasia as a presentation of cat-scratch encephalopathy. 
  • Reimmunization to pneumococcus in patients with sickle cell disease: do they or don't they respond? 
  • Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity. 
  • Rocky Mountain spotted fever in Mississippi: survey for spotted fever antibodies in dogs and for spotted fever group reckettsiae in dog ticks. 
  • Safety and Immunogenicity of DTaP5-IPV Compared With DTaP5 Plus IPV as the Fifth Dose in Children 4-6 Years of Age. 
  • Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children. 
  • Screening Veterans for Syphilis: Implementation of the Reverse Sequence Algorithm. 
  • Serial isolates of persistent Haemophilus influenzae in patients with chronic obstructive pulmonary disease express diminishing quantities of the HMW1 and HMW2 adhesins. 
  • Seroepidemiology of Rickettsia typhi, spotted fever group rickettsiae, and Coxiella burnetti infection in pregnant women from urban Tanzania. 
  • Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States. 
  • Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. 
  • Serologic evidence of respiratory and rickettsial infections among Somali refugees. 
  • Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers. 
  • Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia. 
  • Seroprevalence of antibodies to chlamydia pneumoniae in women with preeclampsia. 
  • Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. 
  • Specificity analysis of antibodies to single-stranded micrococcal DNA in the sera of normal human subjects and patients with systemic lupus erythematosus. 
  • Specificity and immunochemical properties of antibodies to bacterial DNA in sera of normal human subjects and patients with systemic lupus erythematosus (SLE). 
  • Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine. 
  • Spotted fever group rickettsial infections in Australia. 
  • Stable dry powder formulation for nasal delivery of anthrax vaccine. 
  • Stimulation of the immune response by dimethylglycine, a nontoxic metabolite. 
  • Studies of the interaction of antibody and complement with encapsulated bacteria. 
  • Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition. 
  • Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. 
  • Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. 
  • Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen. 
  • The C-terminal fragment of the internal 110-kilodalton passenger domain of the Hap protein of nontypeable Haemophilus influenzae is a potential vaccine candidate. 
  • The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid. 
  • The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. 
  • The antibody response in Lyme disease. 
  • The antigenic properties of bacterial DNA in normal and aberrant immunity. 
  • The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. 
  • The fine specificity of monoclonal anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. 
  • The function of antibody and complement in the lysis of bacteria. 
  • The human antibody response to the surface of Mycobacterium tuberculosis. 
  • The immunologic properties of DNA. 
  • The incidence of Helicobacter pylori in patients with interstitial cystitis. 
  • The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina. 
  • The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen. 
  • The pathogenesis of nontypable Haemophilus influenzae otitis media. 
  • The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation. 
  • The risk of Helicobacter pylori infection among U.S. military personnel deployed outside the United States. 
  • The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream. 
  • The role of bacterial DNA in autoantibody induction. 
  • The role of complement in host resistance to bacteria. 
  • Treponema pallidum infection in the wild baboons of East Africa: distribution and genetic characterization of the strains responsible. 
  • Unsuspected leptospirosis is a cause of acute febrile illness in Nicaragua. 
  • Unsuspected rickettsioses among patients with acute febrile illness, Sri Lanka, 2007. 
  • Use of Peptide-Based Enzyme-Linked Immunosorbent Assay followed by Immunofluorescence Assay To Document Ehrlichia chaffeensis as a Cause of Febrile Illness in Nicaragua. 
  • Use of monoclonal antibodies to probe subunit- and polymer-specific epitopes of 987P fimbriae of Escherichia coli. 
  • Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. 
  • [Rickettsiosis subsequent to vacation in Swaziland]. 
• 

  Keywords of People

  • Gunn, Michael Dee, Professor of Medicine, Immunology
  • Laskowitz, Daniel Todd, Professor of Neurology, Duke Innovation & Entrepreneurship
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic